Issue 18, 2010

Efforts toward elucidating Thalidomide’s molecular target: an expedient synthesis of the first Thalidomide biotin analogue

Abstract

Herein we describe the synthesis of the first Thalidomidebiotin analogue in order to initiate investigations into the unknown molecular mode of action of Thalidomide. In this manner we describe the attachment of biotin tether through the Huisgen 1,3-dipolar cycloaddition or “click” synthetic methodology.

Graphical abstract: Efforts toward elucidating Thalidomide’s molecular target: an expedient synthesis of the first Thalidomide biotin analogue

Supplementary files

Article information

Article type
Communication
Submitted
29 Apr 2010
Accepted
25 Jun 2010
First published
13 Jul 2010

Org. Biomol. Chem., 2010,8, 4059-4062

Efforts toward elucidating Thalidomide’s molecular target: an expedient synthesis of the first Thalidomide biotin analogue

S. G. Stewart, C. J. Braun, M. E. Polomska, M. Karimi, L. J. Abraham and K. A. Stubbs, Org. Biomol. Chem., 2010, 8, 4059 DOI: 10.1039/C0OB00060D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements